Why patients co-diagnosed with ME/CFS do not respond to MT with increased CX3CR1 levels is unknown at present, but it seems to support differential response to MT with ME/CFS co-diagnosis, as previously shown [18]. This evidence concerns the gene CX3CR1 and myalgic encephalomeyelitis/chronic fatigue syndrome.